US Stock MarketDetailed Quotes

CNTX Context Therapeutics

Watchlist
  • 1.0200
  • -0.0700-6.42%
Close Dec 20 16:00 ET
  • 1.0600
  • +0.0400+3.92%
Post 16:56 ET
76.50MMarket Cap-1.16P/E (TTM)

Context Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
44.14%-1.93M
27.54%-3.36M
23.88%-4.36M
-55.34%-21.05M
-83.91%-7.23M
-15.59%-3.46M
-65.09%-4.63M
-49.95%-5.73M
-53.98%-13.55M
20.80%-3.93M
Net income from continuing operations
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
-41.88%-14.84M
-15.04%-3.56M
Operating gains losses
----
----
----
-33.82%51.97K
--0
-65.01%7.52K
5.44%22.37K
57.44%22.08K
-68.12%78.52K
--21.79K
Depreciation and amortization
-9.00%2.81K
-19.60%2.57K
-19.57%2.57K
29.95%12.04K
-19.60%2.57K
-3.26%3.09K
10.86%3.19K
--3.19K
--9.27K
--3.19K
Other non cash items
----
----
----
----
----
----
----
----
-84.00%500K
--0
Change In working capital
-74.67%544.25K
-1,862.27%-1.26M
-444.11%-935.4K
739.84%1.78M
-11.60%-715.91K
284.30%2.15M
-82.80%71.55K
144.50%271.83K
87.53%-277.52K
68.80%-641.51K
-Change in prepaid assets
-108.42%-107.63K
53.35%-212.14K
170.55%647.9K
203.09%758.83K
-294.95%-303.85K
236.90%1.28M
-1.16%-454.72K
-51.23%239.48K
54.32%-736.05K
109.73%155.86K
-Change in payables and accrued expense
-21.79%668.16K
-291.45%-1.05M
-3,317.81%-1.58M
83.39%1.04M
47.23%-412.05K
-42.54%854.29K
-41.21%547.78K
104.59%49.2K
192.39%566.69K
-71.92%-780.82K
-Change in other current assets
--0
--0
--0
200.00%32.75K
--0
-15.60%24K
105.00%2.19K
127.34%6.56K
---32.75K
--6.56K
-Change in other current liabilities
-104.32%-16.28K
--0
--0
26.96%-55.08K
--0
65.11%-7.97K
-5.12%-23.7K
-238.72%-23.41K
---75.41K
---23.12K
Cash from discontinued investing activities
Operating cash flow
44.14%-1.93M
27.54%-3.36M
23.88%-4.36M
-55.34%-21.05M
-83.91%-7.23M
-15.59%-3.46M
-65.09%-4.63M
-49.95%-5.73M
-53.98%-13.55M
20.80%-3.93M
Investing cash flow
Cash flow from continuing investing activities
0
0
-114.73%-536.84K
0
Net PPE purchase and sale
----
----
----
--0
--0
----
----
----
---36.84K
--0
Net intangibles purchase and sale
----
----
----
--0
--0
----
----
----
-100.00%-500K
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
--0
----
----
----
-114.73%-536.84K
--0
Financing cash flow
Cash flow from continuing financing activities
-44.63K
0
0
0
-100.17%-102.07K
0
Net common stock issuance
---44.63K
----
----
----
----
--0
----
----
----
----
Net other financing activities
----
----
----
----
----
----
----
----
---102.07K
--0
Cash from discontinued financing activities
Financing cash flow
---44.63K
----
----
--0
--0
--0
----
----
-100.17%-102.07K
--0
Net cash flow
Beginning cash position
303.92%101.54M
-66.11%10.09M
-59.29%14.45M
-28.56%35.5M
-45.02%21.68M
-41.43%25.14M
-34.90%29.77M
-28.56%35.5M
14,468.97%49.69M
9,306.40%39.43M
Current changes in cash
-383.55%-16.74M
2,074.64%91.45M
23.88%-4.36M
-48.35%-21.05M
-83.91%-7.23M
0.95%-3.46M
-64.98%-4.63M
-44.75%-5.73M
-128.75%-14.19M
-107.98%-3.93M
End cash Position
291.21%84.8M
303.92%101.54M
-66.11%10.09M
-59.29%14.45M
-59.29%14.45M
-45.02%21.68M
-41.43%25.14M
-34.90%29.77M
-28.56%35.5M
-28.56%35.5M
Free cash flow
-382.27%-16.69M
27.54%-3.36M
23.88%-4.36M
-49.42%-21.05M
-83.91%-7.23M
0.95%-3.46M
-64.98%-4.63M
-48.59%-5.73M
-55.66%-14.09M
20.80%-3.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 44.14%-1.93M27.54%-3.36M23.88%-4.36M-55.34%-21.05M-83.91%-7.23M-15.59%-3.46M-65.09%-4.63M-49.95%-5.73M-53.98%-13.55M20.80%-3.93M
Net income from continuing operations -197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M-41.88%-14.84M-15.04%-3.56M
Operating gains losses -------------33.82%51.97K--0-65.01%7.52K5.44%22.37K57.44%22.08K-68.12%78.52K--21.79K
Depreciation and amortization -9.00%2.81K-19.60%2.57K-19.57%2.57K29.95%12.04K-19.60%2.57K-3.26%3.09K10.86%3.19K--3.19K--9.27K--3.19K
Other non cash items ---------------------------------84.00%500K--0
Change In working capital -74.67%544.25K-1,862.27%-1.26M-444.11%-935.4K739.84%1.78M-11.60%-715.91K284.30%2.15M-82.80%71.55K144.50%271.83K87.53%-277.52K68.80%-641.51K
-Change in prepaid assets -108.42%-107.63K53.35%-212.14K170.55%647.9K203.09%758.83K-294.95%-303.85K236.90%1.28M-1.16%-454.72K-51.23%239.48K54.32%-736.05K109.73%155.86K
-Change in payables and accrued expense -21.79%668.16K-291.45%-1.05M-3,317.81%-1.58M83.39%1.04M47.23%-412.05K-42.54%854.29K-41.21%547.78K104.59%49.2K192.39%566.69K-71.92%-780.82K
-Change in other current assets --0--0--0200.00%32.75K--0-15.60%24K105.00%2.19K127.34%6.56K---32.75K--6.56K
-Change in other current liabilities -104.32%-16.28K--0--026.96%-55.08K--065.11%-7.97K-5.12%-23.7K-238.72%-23.41K---75.41K---23.12K
Cash from discontinued investing activities
Operating cash flow 44.14%-1.93M27.54%-3.36M23.88%-4.36M-55.34%-21.05M-83.91%-7.23M-15.59%-3.46M-65.09%-4.63M-49.95%-5.73M-53.98%-13.55M20.80%-3.93M
Investing cash flow
Cash flow from continuing investing activities 00-114.73%-536.84K0
Net PPE purchase and sale --------------0--0---------------36.84K--0
Net intangibles purchase and sale --------------0--0-------------100.00%-500K--0
Cash from discontinued investing activities
Investing cash flow --------------0--0-------------114.73%-536.84K--0
Financing cash flow
Cash flow from continuing financing activities -44.63K000-100.17%-102.07K0
Net common stock issuance ---44.63K------------------0----------------
Net other financing activities -----------------------------------102.07K--0
Cash from discontinued financing activities
Financing cash flow ---44.63K----------0--0--0---------100.17%-102.07K--0
Net cash flow
Beginning cash position 303.92%101.54M-66.11%10.09M-59.29%14.45M-28.56%35.5M-45.02%21.68M-41.43%25.14M-34.90%29.77M-28.56%35.5M14,468.97%49.69M9,306.40%39.43M
Current changes in cash -383.55%-16.74M2,074.64%91.45M23.88%-4.36M-48.35%-21.05M-83.91%-7.23M0.95%-3.46M-64.98%-4.63M-44.75%-5.73M-128.75%-14.19M-107.98%-3.93M
End cash Position 291.21%84.8M303.92%101.54M-66.11%10.09M-59.29%14.45M-59.29%14.45M-45.02%21.68M-41.43%25.14M-34.90%29.77M-28.56%35.5M-28.56%35.5M
Free cash flow -382.27%-16.69M27.54%-3.36M23.88%-4.36M-49.42%-21.05M-83.91%-7.23M0.95%-3.46M-64.98%-4.63M-48.59%-5.73M-55.66%-14.09M20.80%-3.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Micron Technology
MU
+3.48%
NVIDIA
NVDA
+3.08%
Intel
INTC
+2.41%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%

Unlock the Full List